Literature DB >> 18981258

Moving toward the next steps in angiogenesis therapy?

W K Alfred Yung.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18981258      PMCID： PMC2719007          DOI： 10.1215/15228517-2008-091

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  5 in total

1.  Bevacizumab--news from the fast lane?

Authors:  Michael Weller; W K Alfred Yung
Journal:  Neuro Oncol       Date:  2008-09-05       Impact factor: 12.300

2.  VEGF Trap induces antiglioma effect at different stages of disease.

Authors:  Candelaria Gomez-Manzano; Jocelyn Holash; Juan Fueyo; Jing Xu; Charles A Conrad; Kenneth D Aldape; John F de Groot; B Nebiyou Bekele; W K Alfred Yung
Journal:  Neuro Oncol       Date:  2008-08-14       Impact factor: 12.300

3.  Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival.

Authors:  Ashwatha Narayana; Patrick Kelly; John Golfinos; Erik Parker; Glyn Johnson; Edmond Knopp; David Zagzag; Ingeborg Fischer; Shahzad Raza; Praveen Medabalmi; Patricia Eagan; Michael L Gruber
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

4.  Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

Authors:  A D Norden; G S Young; K Setayesh; A Muzikansky; R Klufas; G L Ross; A S Ciampa; L G Ebbeling; B Levy; J Drappatz; S Kesari; P Y Wen
Journal:  Neurology       Date:  2008-03-04       Impact factor: 9.910

Review 5.  Modes of resistance to anti-angiogenic therapy.

Authors:  Gabriele Bergers; Douglas Hanahan
Journal:  Nat Rev Cancer       Date:  2008-08       Impact factor: 60.716
  5 in total
  2 in total

Review 1.  Vascular endothelial growth factor trap-eye (Aflibercept) for the management of diabetic macular edema.

Authors:  Ahmadreza Moradi; Yasir Jamal Sepah; Mohammad Ali Sadiq; Humzah Nasir; Salima Kherani; Raafay Sophie; Diana V Do; Quan Dong Nguyen
Journal:  World J Diabetes       Date:  2013-12-15

Review 2.  The challenges and the promise of molecular targeted therapy in malignant gliomas.

Authors:  Hongxiang Wang; Tao Xu; Ying Jiang; Hanchong Xu; Yong Yan; Da Fu; Juxiang Chen
Journal:  Neoplasia       Date:  2015-03       Impact factor: 5.715
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.